CD8A and cervical cancer: It was reported previously that cervical cancer cell lines exhibited antigen-processing defects for the E629-38 (TIHDIILECV) peptide; however, peptide-specific CD8+ T cells were able to kill CaSki indicating presentation of this peptide in CaSki cells.49